R

REGiMMUNE Corporation

7 employees

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Diagnostics
Biopharma

Date founded

2006

Funding rounds raised

Total raised

$12M

from 27 investors over 27 rounds

R

REGiMMUNE Corporation raised $5.7M on May 10, 2017

Investors: （株）広島ベンチャーキャピタル, 大分ベンチャーキャピタル（株）, ＳＭＢＣベンチャーキャピタル（株）, Miyako Capital, Japan Asia Investment Co., Ltd. and Ogaki Kyoritsu Bank Ltd

R

REGiMMUNE Corporation raised $9.2M on February 14, 2014

Investors: ＳＭＢＣベンチャーキャピタル（株）, ニッセイ・キャピタル（株）, Japan Asia Investment Co., Ltd., Mitsui Sumitomo Insurance (London Management) Ltd, Nippon Life Benefits and NVCC

R

REGiMMUNE Corporation raised $5M on February 1, 2012

Investors: 信金キャピタル株式会社, ＳＭＢＣベンチャーキャピタル（株） and Japan Asia Investment Co., Ltd.

R

REGiMMUNE Corporation raised $12M on December 8, 2008

Investors: Japan Science & Technology Agency (JST)

R

REGiMMUNE Corporation raised $8M on May 6, 2008

Investors: Yasuda Enteprise Development Co. Ltd and Japan Asia Investment Co., Ltd.

R

REGiMMUNE Corporation raised $6M on February 1, 2008

Investors: （株）ファンドクリエーション, AC Ventures Llc, Yasuda Enteprise Development Co. Ltd, Resona Holdings and Japan Asia Investment Co., Ltd.

R

REGiMMUNE Corporation raised $4.2M on February 21, 2007

Investors: （株）ファンドクリエーション, Japan Asia Investment Co., Ltd. and Yasuda Enteprise Development Co. Ltd

R

REGiMMUNE Corporation raised $1.6M on August 15, 2006

Investors: Japan Asia Investment Co., Ltd.

FAQ